Tenet Healthcare Corporation (NYSE: THC) has a price-to-earnings ratio that is above its average at 14.45x. and a 36-month beta value of 2.19.
The public float for THC is 100.56M, and at present, short sellers hold a 4.38% of that float. On March 16, 2023, the average trading volume of THC was 1.66M shares.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
Sponsored
THC) stock’s latest price update
Tenet Healthcare Corporation (NYSE: THC)’s stock price has increased by 0.35 compared to its previous closing price of 54.04. However, the company has seen a -5.85% decrease in its stock price over the last five trading sessions. The Wall Street Journal reported on 06/24/21 that Hospital Stocks’ Rally Points to Post-Covid Growth
THC’s Market Performance
Tenet Healthcare Corporation (THC) has experienced a -5.85% fall in stock performance for the past week, with a -9.72% drop in the past month, and a 22.64% rise in the past quarter. The volatility ratio for the week is 5.38%, and the volatility levels for the past 30 days are at 3.67% for THC. The simple moving average for the last 20 days is -7.26% for THC stock, with a simple moving average of -0.15% for the last 200 days.
Analysts’ Opinion of THC
Many brokerage firms have already submitted their reports for THC stocks, with Loop Capital repeating the rating for THC by listing it as a “Buy.” The predicted price for THC in the upcoming period, according to Loop Capital is $80 based on the research report published on June 17th of the previous year 2022.
Wells Fargo, on the other hand, stated in their research note that they expect to see THC reach a price target of $100. The rating they have provided for THC stocks is “Overweight” according to the report published on March 29th, 2022.
UBS gave a rating of “Buy” to THC, setting the target price at $111 in the report published on February 10th of the previous year.
THC Trading at -1.93% from the 50-Day Moving Average
After a stumble in the market that brought THC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -41.47% of loss for the given period.
Volatility was left at 3.67%, however, over the last 30 days, the volatility rate increased by 5.38%, as shares sank -12.32% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +11.15% upper at present.
During the last 5 trading sessions, THC fell by -5.85%, which changed the moving average for the period of 200-days by -17.23% in comparison to the 20-day moving average, which settled at $58.09. In addition, Tenet Healthcare Corporation saw 11.15% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at THC starting from Arnst Thomas W, who sale 1,600 shares at the price of $60.07 back on Mar 07. After this action, Arnst Thomas W now owns 21,178 shares of Tenet Healthcare Corporation, valued at $96,112 using the latest closing price.
Arnst Thomas W, the EVP, Chief Admin. Officer & GC of Tenet Healthcare Corporation, sale 825 shares at $61.00 during a trade that took place back on Mar 06, which means that Arnst Thomas W is holding 22,778 shares at $50,325 based on the most recent closing price.
Stock Fundamentals for THC
Current profitability levels for the company are sitting at:
- +11.57 for the present operating margin
- +11.86 for the gross margin
The net margin for Tenet Healthcare Corporation stands at +2.14. Equity return is now at value 36.40, with 1.50 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 1.34.
Conclusion
To sum up, Tenet Healthcare Corporation (THC) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
